Colorectal cancer tumor stem cells mediate bevacizumab resistance through the signal IL-22-STAT3 signaling pathway. - Qin, Xiaoning; Ruan, Hongxun; Yuan, Liqing; Lin, Lin (3 Biotech, 2023)